Home / Hemostatic agent / Factor VIII Inhibitor Bypassing Activity (in 20-60 mg human plasma protein)
Back to Search

Factor VIII Inhibitor Bypassing Activity (in 20-60 mg human plasma protein) – Uses, Dosage, and Brands in UAE

Brand Name: FEIBA 500
Strength: 50 U/ml | Form: Powder and solvent for solution for Injection
Price in UAE: AED 2016.50
Available in UAE pharmacies

About Factor VIII Inhibitor Bypassing Activity (in 20-60 mg human plasma protein)

Class: | Hemostatic agent Use: | Treatment and prevention of bleeding episodes in patients with hemophilia A or B who have developed inhibitors to Factor VIII or Factor IX Adult dose: | 50 U (units) administered intravenously; dosing may vary based on the severity of the bleeding episode and patient response Pediatric dose: | Dosing is individualized based on weight and clinical situation; consult a healthcare provider for specific recommendations Side effects: | Thromboembolic events, a

Drug Class

Hemostatic agent

Uses & Indications

Treatment and prevention of bleeding episodes in patients with hemophilia A or B who have developed inhibitors to Factor VIII or Factor IX

Storage Requirements

Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; once reconstituted, use immediately or store at room temperature for a maximum of 3 hours

Manufacturer & Packaging

Manufacturer: Takeda Manufacturing Austria AG (IndustriestraBe 67-Vienna; Austria), Austria

Package Size

10mL (1 Glass Vial of 500 u FEIBA(powder) + 1 Glass Vial of 10ml sterilised WFI +1 BAXJECT II Hi-Flow+1 disposable syringe 10 ml + 1 butterfly needle+ 1 disposable needle)

Price & Supplier

Price in UAE: AED 2016.50

Dosage Information

Adult Dose

50 U (units) administered intravenously; dosing may vary based on the severity of the bleeding episode and patient response

Pediatric Dose

Dosing is individualized based on weight and clinical situation; consult a healthcare provider for specific recommendations

Side Effects

Thromboembolic events, allergic reactions, fever, headache, nausea, and infusion site reactions

Contraindications & Precautions

Known hypersensitivity to any component of the product; history of thromboembolic events; caution in patients with a history of cardiovascular disease

Important Warnings

Monitor for signs of thrombosis; use with caution in patients with risk factors for thromboembolic events; ensure appropriate laboratory monitoring of coagulation parameters during treatment

Related Medicines in Same Category

See also: Other Hemostatic agent medicines available in UAE pharmacies

Etamsylate Etamsylate Etamsylate Human Thrombin Human Thrombin Thrombin Thrombin Topical (Recombinant) Thrombin Topical (Recombinant)

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Hemostatic agent Medicines Browse All Categories